A group of Blood Bank of Alaska employees have filed a complaint with the U.S. Food and Drug Administration charging the BBA leadership with mismanagement and financial impropriety leading to dangerous donor conditions and blood shortages.
According to the complaint, filed Aug. 28, the BBA allegedly could not fill the order of Providence Medical Center when it had its grand opening because too much blood had been shipped to California the day before.
Blood Bank representatives did not respond to numerous requests for comment.
In correspondence with Linda Soriano, the blood bank’s former grant writer, the FDA confirmed receipt of the complaint, but is not able to comment on ongoing investigations.
Soriano spearheaded a group of employees whose names are being held confidential by the FDA, alleging that the blood bank has been shedding donors as the result of a vigorous campaign to supply the blood needs of both Alaska and a California blood bank it has an export contract with.
Soriano served as the Blood Bank of Alaska’s grant writer since 2012 and as development manager since 2015. She tendered her letter of resignation on Sept. 11.
Prior, she worked as the grants officer for Christian Health Associates and Providence Health & Services Alaska, the company that owns Providence Medical Center Alaska.
Soriano blames the alleged blood bank shortages on costs of the new building.
“The irony is that BBA could have built a $33M facility that was right-sized for Alaska’s needs and moved into it debt free,” Soriano wrote in an email. “All of the corner cutting, exporting and lack of financial transparency could have been avoided if we hadn’t gone forward with the Taj Mahal of blood banks.”
Despite repeated appeals to state and federal elected officials, Soriano said she has had no luck finding actionable ways to address the blood bank’s issues.
After conversations with state Sen. Berta Gardener and U.S. Sen. Lisa Murkowski, Soriano lamented that no government agency apart from the Food and Drug Administration oversees the blood bank.
According to the complaint, the blood bank has a “severe and ongoing lack of inventory” due to blood export contracts made to meet the expense of the blood bank’s new building loan.
After moving into its $45.7 million, 57,000 square foot building earlier this year, the Blood Bank of Alaska entered an agreement with LifeStream, a California blood center, to export 100 units of blood per week, all the while ramping up recruitment for more donors in Alaska.
The building was funded with $32.8 million from the state capital budget, an $8.5 million loan from the Alaska Industrial Development and Export Authority, and a $3 million donation from ConocoPhillips.
In prior interviews, blood bank board members and CEO Bob Scanlon have insisted that such export agreements are commonplace in the industry. No Alaska hospitals, they said, have been shorted on blood supply.
They said the blood export agreement with LifeStream has no connection to the building’s finances, but is simply a way for the BBA to more effectively manage blood to maximize efficiency.
The complaint claims BBA has struggled with shortages since late spring when it moved into the new building.
On the day of the new building’s grand opening ceremony May 20, Soriano and a colleague found six or seven units of O negative and trays of AB negative, the latter of which the Director of Hospital Services said none of the hospitals wanted. May 20 fell on a Friday. BBA ships blood units to California every Thursday.
After the grand opening, Soriano and several BBA employees warned Alaska’s largest hospitals — Alaska Regional Hospital, Providence Medical Center, and Alaska Native Medical Center Hospital — of the shortage.
Providence did not confirm or deny the shortage in an emailed statement.
“The Blood Bank of Alaska has consistently provided uninterrupted service to Providence Alaska Medical Center, including during its recent move into a new building,” wrote senior manager of external communications Mikal Canfield to the Journal.
“The blood bank worked with Providence prior to the move to ensure we had enough blood supply to meet our requests during the move.”
The complaint said BBA has run low on blood several times since then, and has tried to import blood from the Lower 48 without any luck due to national blood shortages.
To secure more blood, BBA has increased donor recruitment and donor collections. According to Soriano, “donors are besieged by texts, emails and robo-calls that are causing many longtime donors to remove their names from our lists permanently.”
According to the complaint, the need for more export blood led to overdrawing some donors and to drawing less than usual per unit in order to meet the demands of the LifeStream contract.
The BBA employees say leadership has a record of financial impropriety, alleging Scanlon gave Soriano inaccurate financial reports to submit to potential BBA grant givers, including a projection of $25,000 to $41,000 per month in unrestricted gifts, which BBA has no history of receiving, Soriano said.
“The financials are definitely being manipulated to make BBA’s financial situation appear more stable than it is,” Soriano wrote in the complaint.
When she asked for budgets to present to grant givers, she received numbers that were “clearly incorrect and showed the monthly (line of credit) payment as $26K when it was actually $47K a month per an email I later received from the CEO,” Soriano wrote in the complaint.
In previous interviews, Scanlon confirmed that the monthly payment on the building loan was roughly $40,000.
Soriano said she recently received updated financials with year-to-date actuals through June 30 that appear more realistic.
In search for more funding, during an August meeting Scanlon asked Murkowski’s Chief of Staff Michael Pawlowski and Legislative Director Garrett Boyle for a $2 million federal grant and an FDA waiver to import blood directly from Canada.
Karina Peterson, Murkowski’s director of communications, confirmed that the meeting took place and involved the requests Soriano described in the complaint, though she didn’t confirm Soriano’s characterization of Scanlon as “belligerent.”
DJ Summers can be reached at daniel.summers@alaskajournal.com.
